Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal reflex, absent
acetylcholine receptor
acetylcholine receptor antibody
acyclovir
adalimumab
advances in neurology
adverse drug reaction
algorithm
AMPA receptor antibodies
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, work up
anemia
angiotensin-converting enzyme
anti GQ1b IgG antibody
anti Yo antibody
anxiety
aphasia
arachnoiditis
area postrema
area postrema syndrome
aspergillosis
ataxia
ataxia, cerebellar
ataxia, progressive
atypical
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autonomic dysfunction
azathioprine
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavioral disorder
behavioral disorder, acute
Behcet's syndrome
blacks
bone marrow biopsy
bone marrow transplantation
brachial plexus injury
brachial plexus neuropathy
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem, lesion of
burning paresthesia
carcinoma
carcinoma of breast
carcinoma of ovary
cardiac surgery
cardiac surgery, neurologic complications with
cardiac transplantation
CAT scan
CAT scan, abnormal
CAT scan, chest
CAT scan, contrast enhanced, subepend.
CAT scan, emission, abnormal
catatonia
cauda equina, lesion of
central nervous system, infection of
cerebellitis
cerebellitis, autoimmune
cerebellum, disease of
cerebral cortex
cerebral edema
cerebral ischemia
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS tumors
cerebrospinal fluid, cytology
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident
chairbound
chemotherapy, CNS treatment and complications with
children
chorea
choreoathetosis
Clinical Pathologic Conference(C.P.C.)
cognition
collapsin response mediator protein 5 IgG
comorbidities
complications
conduction block
confusion
confusional state, acute
congenital malformation
controversies in neurology
corpus callosum, lesion of
cranial nerve palsies
cranial neuropathy
critical care unit
cyclophosphamide
cyclosporine
daclizumab
delay in diagnosis
dementia
dentate nuclei
dentate nuclei, lesion of
diabetes insipidus
diagnostic criteria
diarrhea
differential diagnosis
diplopia
DPPX, antibodies, encephalitis
drug induced neurologic disorders
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, facial
dystonia
eculizumab
efgartigimod alfa
electroencephalogram, abnormalities of
electrophoretic pattern, serum
emotional lability
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy
encephalopathy, anoxic
epidemiology of neurology
Epstein-Barr virus
etanercept
face, numbness of
facial nerve palsy
facial nerve palsy, bilateral
faciobrachial dystonic seizure
false negative
false positive
fatigue
fever
fungal infection, CNS
gadolinium
gait disorder
gallium scan
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gender
glutamic acid decarboxylase, antibody
GM1 ganglioside antibodies
granulomatous disease
granulomatous hypophysitis
Guillain Barre syndrome
headache
headache, severe
hearing loss
hemiparesis
herpes simplex encephalitis
herpes simplex encephalitis, atypical
herpes simplex virus infection, immunosuppressed patient
herpes zoster
hiccoughs
hippocampus
HLA
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hydrocephalus
hypercalcemia
hyperekplexia
hypertrophic intracranial pachymeningitis
hypoglycorrhachia
hyponatremia
hypothalamus, lesion of
iatrogenic neurologic disorders
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
in situ hybridization
inappropriate antidiuretic(A.D.H.)hormone
infection
infliximab
insomnia
intellectual deficit
ipilimumab
iritis
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
leucine rich glioma inactivated 1 antibodies
leukemia
leukemia, neurologic findings assoc.with
level of consciousness, decreased
limbic encephalitis
lipoprotein receptor-related protein 4
lumbar puncture
lymph node biopsy
lymphadenopathy
lymphadenopathy, cervical
lymphadenopathy, hilar
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
lymphopenia
mediastinum, lymph-node biopsy
mediastinum, mass of
medulla oblongata
medulla oblongata, lesion of
melanoma, malignant
memory, defect of recent
memory, impairment of
meningeal enhancement
meningismus
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, basilar
meningitis, carcinomatous
meningitis, chronic
meningitis, drug induced
meningitis, iatrogenic
meningitis, listeria monocytogenes
meningitis, lymphomatous
meningitis, neutrophilic
meningitis, noninfectious
meningitis, pneumococcal
meningitis, recurrent
meningitis, TB
meningoencephalopathy
meningomyelitis
mental status, abnormal
mercaptopurine
mesial temporal lobe
monoclonal antibodies
monoclonal antibodies for tumor cells in CSF
monoclonal gammopathy
mononeuropathy
mononeuropathy multiplex
mortality
motor neuron disease
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, cloud-like
MRI, disappearing lesion on
MRI, false negative
MRI, FLAIR
MRI, negative
MRI, spinal cord
multiple myeloma
multiple sclerosis
multiple sclerosis, treatment of
muromonab-CD3
muscle weakness
MuSK antibodies
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, drug resistant
myasthenia gravis, ocular
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
mycophenolate
myelitis
myelitis, longitudinal
myelitis, transverse
myelitis, transverse, recurrent
myelopathy
myocarditis
myoclonus
myopathy
myositis
natalizumab
nausea and vomiting
neck stiffness
negative
neoplasm, metastatic to CNS
neoplasm, primary of CNS
nerve biopsy
nerve conduction studies
nerve conduction studies, motor
neurexin-3 alpha antibodies
neurologic complications of, systemic cancer
neurologic complications of, systemic disease
neurologic disease
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal cell surface antigen
neuropathy
neuropathy, iatrogenic
neuropathy, medication induced
neurotoxic
night sweats
nivolumab
NMDA antagonists
ocrelizumab
oculovestibular reflex
ophelia syndrome
ophthalmoplegia
opportunistic infection
opportunistic infection, CNS
optic chiasm
optic chiasm, lesion of
optic nerve, lesion of
optic neuritis
optic neuropathy
organ transplantation
paraneoplastic cerebellar degeneration
paraproteinemia
paresthesias
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
pembrolizumab
peripheral blood stem cell transplantation
personality change
pituitary stalk
pituitary stalk, enlarged
plasmapheresis
plasmapheresis, complications of
pleocytosis of cerebrospinal fluid
pleocytosis of cerebrospinal fluid, neutrophilic
polymerase chain reaction
polymerase chain reaction, false negative
polyneuropathy, chronic inflammatory demyelinating
pons, lesion of
post transplant lymphoproliferative disease
postoperative neurologic complications
potassium channel antibodies
practice guidelines
precipitating factors
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
psoriatic arthritis
psychiatric problems in neurologic disorders
psychosis
ptosis
ptosis, bilateral
pulmonary infiltrates
quadriparesis
quality of life
radiation therapy, CNS treatment and complications with
rash
ravulizumab
recurrent
regional enteritis
remote effect of cancer on the nervous system
renal transplantation
retrovirus
review article
rheumatoid arthritis
risk factors
rituximab
Romberg's sign
rozanolixizumab
safety
sarcoidosis
sarcoidosis, CNS
screening
seizure
serologic testing
serologic testing, false negative
seronegative
skin, lesions in neurologic disorders
sleep pathology and physiology
somnolence
spinal cord, lesion of
steroid
steroid sparing therapy
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
systemic illness
tacrolimus
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thalamus, lesion of
thalamus, lesion of-bilateral
thrombocytopenia
thymectomy
thymic hyperplasia
thymoma
thyroiditis
toxoplasmosis, CNS
transient ischemic attack
treatment of neurologic disorder
tremor
tuberculosis
tumor necrosis factor inhibitor
uveitis
ventricular assist device
viral infection
viral infection, CNS
vision, blurred
visual impairment
visual loss
vomiting, intractable
walking, difficulty with
water channel antibodies
weakness
weakness, fatiguable
weakness, generalized
weight loss
white matter disease
white matter disease, subcortical
workup
zilucoplan
Showing articles 250 to 300 of 5134 << Previous Next >>

Treatment of Refractory Neurosarcoidosis with Infliximab
JNNP 81:241-246, Santos,E., et al, 2010

Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Transverse Myelitis
NEJM 363:564-572, Frohman,E.M. &Wingerchuk,D.M., 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Glucose Transporter-1 Deficiency Syndrome: The Expanding Clinical and Genetic Spectrum of a Treatable Disorder
Brain 133:655-670, Leen,W.G., et al, 2010

Leptomeningeal Metastases in the MRI Era
Neurol 74:1449-1454, Clarke,J.L., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Clinicopath Conf, Intravascular Large-B-Cell Lympoma
NEJM 362:1129-1138, Case 9-2010, 2010

Anti-N-Methyl-d-Aspartate Receptor Encephalitis: Characteristic Behavioral and Movement Disorder
Arch Neurol 67:250-251, Ferioli,S.,et al, 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Nosocomial Bacterial Meningitis
NEJM 362:146-154, van de Beek,D.,et al, 2010

Reversible Paraneoplpastic Limbic Encephalitis Associated with Antibodies to the AMPA Receptor
Neurol 74:265-267, Bataller,L.,et al, 2010

Cerebrospinal Fluid Study in Paraneoplastic Syndromes
JNNP 81:42-45, Psimaras,D.,et al, 2010

Acute Toxoplasmosis Infection in a Patient with Ankylosing Spondylitis Treated with Adalimumab: A Case Report
Reumatismo 62:283-285, Azevedo V.F., et al, 2010

Tumefactive Multiple Sclerosis
www.medlink.com, JUne, Bunyan, R.F. and Lucchinetti, C.F., 2010

Carcinomatous Meningitis from Adenocarcinoma of the Uterine Cervix: A Case Report and Literature Review
J Obstet Gynaecol Res 36:444-447, Yamauchi, N.,et al, 2010

Meningeal Carcinomatosis and Uterine Carcinoma
Int J Gynecol Cancer 19:168-172, Asensio, N.,et al, 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Anti-N-Methyl-D-Aspartate Receptor (NHMDAR) Encephalitis in Children and Adolescents
Ann Neurol 66:11-18,1, Florance,N.R.,et al, 2009

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Voltage-gated Potassium Channel-associated Limbic Encepahlitis in the West of Scotland:Case Reports and Literature Review
Scott Med J 54:27-31, Reid,J.M.,et al, 2009

Paraneoplastic Syndromes Affecting Brain and Cranial Nerves
UpToDate May 2009, Dalmau,J. &Rosenfeld,M., 2009

Multifocal Paraneoplastic Cortical Encephalitis Associated With Myasthenia Gravis and Thymoma
Arch Neurol 66:1407-1409, Hammoud,K.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Differential Diagnosis of Postpartum Headaches
Rev Mex Anest 32:Suppl1 S16-S23, MacArthur,A., 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Natalizumab and Central Nervous System Lymphoma: No Clear Association
Ann Neurol 66:261-262, Bozic,C.,et al, 2009

Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Clinicopath Conf, Atypical Carcinoid Tumor with Limbic Encephalitis
NEJM 359:2155-2164, Case 35-2008, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Meningeal Dissemination in Primary CNS Lymphoma: Prospective Evaluation of 282 Patients
Neurol 71:1102-1108, Fischer,L.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008



Showing articles 250 to 300 of 5134 << Previous Next >>